Postoperative Pain Control for Prostatectomy
- Conditions
- Prostate Cancer
- Registration Number
- NCT00913068
- Lead Sponsor
- Nova Scotia Health Authority
- Brief Summary
The researchers propose to investigate a relatively new anesthetic procedure, in order to maximize patient comfort and minimize the use of narcotics after a radical prostatectomy.
- Detailed Description
Our current post operative analgesic strategy involves a multi-modal approach, using local injectable anesthetic around the incision and systemic medications (i.e. non-steroidal anti-inflammatories, acetaminophen and break-through doses of opiates). As the amount of opiates used can be significant, we have to be aware of their inherent risks. Opiates have an excellent pain control profile, working peripherally by decreasing the amount of neurotransmitters released from neurons involving noxious stimuli, and also in their central processing. Some of the more common adverse reactions are reparatory depression, sedation, confusion, delirium, nausea, pruritis, constipation, hypotension and bradycardia. Often it is these resulting side effects that extend the length of in hospital rehabilitation, and decrease a patient's overall satisfaction.
Thus we propose the use of a relatively new regional anesthetic technique be employed to further decrease the need for opiates in our prostatectomy patients' post-op course, while adequately controlling their pain.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Male
- Target Recruitment
- 110
- prostate cancer for radical prostatectomy
- chronic pain or opiate use
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Total Milligrams of Opiates 2, 6,12, 24, 48 and 72 hours mean number of milligrams used postoperatively
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Queen Elizabeth Health Sciences Centre
🇨🇦Halifax, Nova Scotia, Canada
Queen Elizabeth Health Sciences Centre🇨🇦Halifax, Nova Scotia, Canada